Tested Applications
| Positive WB detected in | HEK-293T cells, HeLa cells, HepG2 cells, Jurkat cells, NIH/3T3 cells |
| Positive IHC detected in | human liver cancer tissue, mouse kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:400-1:1600 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
55201-1-AP targets SET/TAF-I in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | SET nuclear oncogene |
| Calculated Molecular Weight | 33 kDa |
| Observed Molecular Weight | 41 kDa, 39 kDa |
| GenBank Accession Number | NM_003011 |
| Gene Symbol | SET |
| Gene ID (NCBI) | 6418 |
| RRID | AB_10837360 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q01105 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SET, also named as IGAAD, I-2PP2A, TAF-I, IGAAD and PHAPII, belongs to the nucleosome assembly protein (NAP) family.SET is a multifunctional oncoprotein which is ubiquitously expressed in all kinds of cells. The SET protein participates in many cellular processes including cell cycle, cell migration, apoptosis, transcription, and DNA repair. The SET protein plays important roles in facilitating cell growth and proliferation via many pathways that promote tumorigenesis and metastasis. The SET protein shows apparent molecular masses of 41 and 39 kDa (PMID: 12759364, PMID: 7753797).
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SET/TAF-I antibody 55201-1-AP | Download protocol |
| WB protocol for SET/TAF-I antibody 55201-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
SET/TAF-I Polyclonal antibody (55201-1-AP) has 19 total citations appearing in journals including Cell Reports, Journal of Medicinal Chemistry, Oncotarget, Marine Drugs, Cancers, Cellular Signalling, Oncology Reports, Biomedicines, Journal of Biological Chemistry, BMC Cancer, Oral Diseases, Journal of Cellular Biochemistry, Virology, Journal of Pediatric Surgery, and STAR Protocols. The research fields associated include cancer biology (lung, gastric, pancreatic, medulloblastoma, neuroblastoma, hepatoblastoma), SET/PP2A signaling, epigenetics, chemical inhibitor discovery, drug resistance, metastasis, and cell migration/proliferation studies.
| Species | Application | Title |
|---|---|---|
Cell Rep A p53/LINC00324 positive feedback loop suppresses tumor growth by counteracting SET-mediated transcriptional repression
| ||
J Med Chem Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner | ||
J Med Chem Discovery of Novel Oxazolo[4,3-f]purine Derivatives as Antitumor Agents through PPIA Interaction | ||
J Med Chem Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies. | ||
Oncotarget Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
|













